Minerva Neurosciences Inc. buy DomRuinart
Summary
This prediction ended on 17.10.22 with a price of €5.67. The BUY prediction by DomRuinart for Minerva Neurosciences Inc. performed very badly with a performance of -34.41%. DomRuinart has 50% into this predictionMinerva Neurosciences (NASDAQ: NERV) is a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients suffering from neuropsychiatric disorders. With a primary emphasis on central nervous system diseases such as schizophrenia, major depressive disorder, insomnia, and Parkinson's, Minerva Neurosciences is committed to addressing unmet medical needs and advancing the understanding of the underlying biology of these conditions. Utilizing a strong research and development platform, the company aims to create a diversified portfolio of novel therapies that have the potential to significantly improve patients' quality of life and help them lead more fulfilling lives.
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Minerva Neurosciences Inc. | 2.459% | 2.459% | -61.948% |
iShares Core DAX® | -1.114% | 3.430% | 25.966% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% |
According to DomRuinart what are the pros and cons of Minerva Neurosciences Inc. for the foreseeable future?
Pros
Cons
Comments by DomRuinart for this prediction
In the thread Minerva Neurosciences Inc. diskutieren
In the thread Trading Minerva Neurosciences Inc.